MYGN
Myriad Genetics Inc.
$6.37
+$0.15(+2.41%)
38
Overall
--
Value
33
Tech
44
Quality
Market Cap
$540.59M
Volume
2.58M
52W Range
$3.76 - $29.30
Target Price
$7.42
Key Metrics Overview
| Market Cap | $540.59M | P/E Ratio | N/A |
| 52W High | $29.30 | 52W Low | $3.76 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | -41.7% | 52W Position | 10.2% |
| Overall Score | 38 | Value Score | -- |
| Quality Score | 44 | Technical Score | 33 |
Growth Analysis
| EPS Current Est | $-0.4 | EPS Next Est | $-0.29 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MYGN | $6.37 | +2.4% | 2.58M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |